8.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NEO Giù?
Forum
Previsione
Frazionamento azionario
Neogenomics Inc Borsa (NEO) Ultime notizie
Aberdeen Group plc Buys 1,006,676 Shares of NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics (NEO) COO nets shares after 17,562-unit RSU vesting - Stock Titan
NeoGenomics (NEO) CEO exercises RSUs and uses shares to cover taxes - Stock Titan
NeoGenomics Inc stock: Precision oncology leader facing growth hurdles - AD HOC NEWS
NeoGenomics, Inc. (NEO) stock price, news, quote and history - Yahoo Finance UK
NeoGenomics Inc Stock: Precision Oncology Leader Faces Growth Challenges in Competitive Diagnostics - AD HOC NEWS
NEO|Neogenomics Inc|Price:8.000|Chg%:0.25 - TradingKey
Growth Value: Why is NeoGenomics Inc stock going upWeekly Market Outlook & Capital Efficient Trade Techniques - baoquankhu1.vn
Geopolitics Watch: Will NeoGenomics Inc outperform the market in YEAR2026 Intraday Action & Community Consensus Trade Signals - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (NEO) Movement - Stock Traders Daily
NeoGenomics Inc Stock: A Key Player in Cancer Diagnostics Amid Evolving Healthcare Demands - AD HOC NEWS
Loss Report: Should you buy the dip on NeoGenomics Inc2026 Summary & Consistent Return Investment Signals - baoquankhu1.vn
NeoGenomics Q2 2025 Earnings Preview - MSN
Tudor Investment Corp ET AL Sells 320,361 Shares of NeoGenomics, Inc. - National Today
Tudor Investment Corp ET AL Sells 320,361 Shares of NeoGenomics, Inc. $NEO - MarketBeat
GRI Bio (NASDAQ:GRI) versus NeoGenomics (NASDAQ:NEO) Financial Contrast - Defense World
Vanguard files 13G/A: NeoGenomics (NEO) ownership shows 0 shares - Stock Titan
Dip Buying: Whats the analyst consensus on NeoGenomics Inc2026 Selloffs & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
NeoGenomics, Inc. (NASDAQ: NEO) Q4 2025 earnings call transcript - MSN
NeoGenomics invites engagement on innovation in oncology at USCAP event - Traders Union
NeoGenomics slides more than 5% despite fourth-quarter earnings beat - MSN
Aug PreEarnings: Is NeoGenomics Inc stock a falling knife or bargain buyTake Profit & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Aug Retail: Is NeoGenomics Inc gaining market share2026 WrapUp & Fast Entry High Yield Tips - baoquankhu1.vn
Aug Chart Watch: Can NeoGenomics Inc deliver alpha2026 Institutional Moves & Smart Allocation Stock Reports - baoquankhu1.vn
NEO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NeoGenomics (NEO) launches RaDaR ST to capture share in $20B MRD market - msn.com
Discipline and Rules-Based Execution in NEO Response - Stock Traders Daily
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Medicare Coverage for PanTracer LBx Liquid Biopsy Could Be A Game Changer For NeoGenomics (NEO) - simplywall.st
NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market - Insider Monkey
11 Most Buzzing Stocks to Buy with the Highest Upside Potential - Insider Monkey
NeoGenomics offers preview of booth presence at USCAP2026 - Traders Union
NeoGenomics Beats Investor Suit Over Growth Driver Claims - Law360
Will Medicare Coverage for PanTracer LBx Liquid Biopsy Shift NeoGenomics' (NEO) Diagnostic Narrative? - Yahoo Finance
NeoGenomics, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo
Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness - simplywall.st
NeoGenomics’ PanTracer LBx test receives Medicare coverage By Investing.com - Investing.com Australia
Neogenomics stock gets Medicare coverage for blood-based test By Investing.com - Investing.com Australia
NEO NeoGenomics, Inc. Maintained: Cowen Buy, William Blair Market Perform Mar 2026 - Meyka
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
NeoGenomics, Natera, and Amphastar Pharmaceuticals shares skyrocket, what you need to know - MSN
NeoGenomics Gets Dismissal of Cancer Test Misrepresentation Suit - Bloomberg Law News
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling - BioSpace
William Blair reiterates Market Perform on Neogenomics stock after Medicare coverage decision - Investing.com Australia
Neogenomics stock gets MolDX reimbursement for cancer test By Investing.com - Investing.com Australia
Neogenomics stock gets Medicare coverage for blood-based test - Investing.com
NeoGenomics test gains Medicare coverage for cancer care - Gulfshore Business
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biop - pharmiweb.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):